Skip to main content

Table 2 Clinical characteristics at index date

From: Impact of oral osteoarthritis therapy usage among other risk factors on knee replacement: a nested case-control study using the Osteoarthritis Initiative cohort

 

Knee replacement

Case (n = 218)

Control (n = 540)

 

(n = 204)

(n = 537)

BMI ≥ 27 kg/m2, % (n)

75.0% (153)

70.6% (379)

WOMAC, median (IQR)

 Pain (0–20)

6.0 (4.0–9.0)

5.0 (3.0–8.0)

 Function (0–68)

22.2 (14.9–31.0)

18.0 (8.5–25.5)

 Stiffness (0–10)

3.0 (2.0–4.0)

3.0 (2.0–4.0)

 Total (0–98)

31.2 (21.8–43.0)

25.0 (13.0–37.0)

KOOS, median (IQR)

 Pain (0–100)

61.1 (47.2–72.2)

66.7 (55.6–79.3)

 Symptoms (0–100)

64.3 (50.0–78.6)

75.0 (58.9–85.7)

 QoL (0–100)

43.8 (31.3–56.3)

56.3 (43.8–68.8)

Kellgren-Lawrence grade, % (n)

 0

1.4% (3)

1.7% (9)

 1

3.7% (8)

3.7% (20)

 2

19.3% (42)

23.9% (129)

 3

31.6% (69)

29.8% (161)

 4

44.0% (96)

40.9% (221)

 

(n = 211)

(n = 524)

JSW (mm), median (IQR)

2.0 (0.8–4.6)

2.8 (1.1–4.6)

Cartilage volume (mm3), median (IQR)

(n = 201)

(n = 510)

 Global knee

11,037 (9127 - 13,634)

11,058 (9351 - 13,508)

 Medial compartment

5127 (3971 - 6482)

5219 (4176 - 6502)

 Lateral compartment

6028 (4864 - 7480)

6043 (4970 - 7265)

BML

(n = 201)

(n = 511)

 Global

  Median (IQR)

2.0 (0.6–4.4)

1.7 (0.4–3.8)

  BML ≥ 1%, % (n)

65.7% (132)

61.5% (314)

 Medial compartment

  Median (IQR)

0.014 (0.0–0.058)

0.021 (0.0–0.057)

  BML ≥ 1%, % (n)

34.9% (76)

42.2% (228)

 Lateral compartment

  Median (IQR)

0.005 (0.0–0.025)

0.0 (0.0–0.018)

  BML ≥ 1%, % (n)

23.9% (52)

20.7% (112)

 

(n = 215)

(n = 532)

Meniscal extrusion, % (n)

39.5% (85)

38.5% (205)

  1. Data shown are proportion of patients (%), number of patients (n), or median (interquartile range (IQR))
  2. BMI body mass index, BML bone marrow lesions, JSW joint space width, KOOS Knee injury and Osteoarthritis Outcome Score, QoL quality of life, WOMAC Western Ontario and McMaster Universities Osteoarthritis Index